StemCells to acquire subsidiaries, assets of U.K. biotech firm

03/2/2009 | American City Business Journals

London-based Stem Cell Sciences has agreed to sell its operating units and certain related assets to StemCells for about $715,000 in cash and 2.65 million shares of stock. The deal, which was cleared by both firms' boards of directors, covers stem cell technologies as well as expertise and infrastructure for cell-based assays used in treatment discovery and testing.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA